We previously reported MASTL kinase inhibitor-1 (MKI-1), a new MASTL inhibitor, showing antitumor activities across in vitro and in vivo tumor models by inhibiting MASTL in breast cancer cells [22]. This evidence concerns the gene MASTL and neoplasm.